Does it really matter if you win or lose the genetic lottery?
By Joseph L Graves Jr,
The Lancet
| 01. 01. 2022
Kathryn Paige Harden, Professor of Psychology who leads the Developmental Behavior Genetics lab at the University of Texas at Austin, USA, is considered by many in her field as an up and coming superstar. Her book, The Genetic Lottery: Why DNA Matters for Social Equality, proposes that an individual's genetic composition, specifically related to their capacity to succeed at education, has an important role in determining their social outcomes. Harden examines the role that an individual's genetic predisposition may have in contributing to their position in society.
To make her case, Harden relies on, for example, results of studies that have associated polygenic scores (PGS) with educational attainment. PGS are derived from genome-wide association studies and identify variants that are statistically associated with a given phenotype. Harden summarises results from a series of PGS studies that indicate that they predict educational attainment, and that educational attainment is associated with a number of social outcomes including greater wealth. None of this is particularly controversial to people who know genetics. The traits of all organisms, behavioural and otherwise, result from the complex...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...